3867 results for «2019»

Filter By

3867 results

Coronary issues before, during and after TAVI

16 May 2024 – From EuroPCR 2024

This session presents a series of challenging clinical cases highlighting the complex interplay between coronary artery disease and transcatheter aortic valve implantation (TAVI). Attendees will witness real-world scenarios, including high-risk PCI with concomitant severe aortic stenosis, the management of degenerated aortic bioprostheses with the risk of...

Coronary issues before, during and after TAVI

Other coronary interventions: SSO2, angioPy & more

16 May 2024 – From EuroPCR 2024

This session showcases a diverse array of innovative coronary interventions and technologies, including the use of super-saturated oxygen therapy in STEMI, the validation of intracoronary flow velocity measurement, the application of laser and optics-based coronary intravascular lithotripsy, and the development of contrast-free and X-ray-free PCI techniques....

Other coronary interventions: SSO2, angioPy & more

Percutaneous tricuspid treatment in challenging anatomies

16 May 2024 – From EuroPCR 2024

Watch this session on percutaneous tricuspid treatment to explore key cases, including managing tricuspid valve-in-valve implantation in a patient with a giant right atrium, transcatheter edge-to-edge repair post-Mustard procedure, and tricuspid replacement in a challenging extreme anatomy case. You'll also learn about cross-caval treatment for torrential...

Percutaneous tricuspid treatment in challenging anatomies

TAVI updates: expanding indications

14 May 2024 – From EuroPCR 2024

This session presents the latest updates and evidence on the expanding indications for transcatheter aortic valve implantation (TAVI). It covers topics such as the impact of unfavorable aortic valve anatomy on TAVI outcomes, sex-specific differences in cardiac damage in aortic stenosis patients undergoing TAVI, the use...

TAVI updates: expanding indications

Acute coronary syndrome caused by coronary aneurysms

16 May 2024 – From EuroPCR 2024

This session will explore various cases of acute coronary syndromes caused by coronary artery aneurysms. Participants will learn about the diagnosis, management, and treatment strategies for these rare and complex cases, including the use of imaging and interventional techniques to address the underlying pathology.

Acute coronary syndrome caused by coronary aneurysms

CTO within a bifurcation

16 May 2024 – From EuroPCR 2024

This session will present various cases of chronic total occlusions (CTOs) within a bifurcation. Participants will learn about the challenges, diagnostic techniques, and treatment strategies for these complex cases, including the use of IVUS, CT angiography, and the hybrid algorithm for successful CTO interventions.

CTO within a bifurcation

ANOCA/INOCA: when angiography is not enough to reach a diagnosis

16 May 2024 – From EuroPCR 2024

This session provides practical knowledge on the diagnosis and management of patients with ANOCA/INOCA (Angina with Non-Obstructive Coronary Arteries/Ischemia with Non-Obstructive Coronary Arteries). It covers the evaluation of microvascular and vasomotor disorders in patients with non-obstructive coronary arteries, and the causes and management of patients with...

ANOCA/INOCA: when angiography is not enough to reach a diagnosis

PCR's Got Talent - Round 2 - Session 2

15 May 2024 – From EuroPCR 2024

This session features a selected abstract submission from EuroPCR 2024 on plaque characterization, outcomes, and predictors of recurrent events in stent failure, as studied using optical coherence tomography (OCT).

PCR's Got Talent - Round 2 - Session 2

PCR's Got Talent - Round 2 - Session 1

15 May 2024 – From EuroPCR 2024

PCR's Got Talent - Round 2 - Session 1

Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis

24 Sep 2021

Structural valve deterioration remains the Achilles heel of both SAVR and TAVI. Since indications for TAVI have expanded to low-risk patients in 2019, this clinical scenario poses a significant conundrum for physicians and surgeons, as the number of patients undergoing aortic valve interventions continues to grow...

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Patrick M. Looser

Reviewer

Patrick M. Looser
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis

PCR STATEMENT on evolving indications for transcatheter aortic valve implantation

21 May 2019

Paris, France, 21 May 2019. Severe symptomatic aortic stenosis, a degenerative disease-causing calcification and immobility of the aortic valve leaflets leading to left ventricular outflow obstruction, is the most common valve lesion leading to intervention in Europe and the USA. Symptoms include heart failure, syncope and...

Evolving indications for transcatheter aortic valve implantation

PCR and EAPCI Statement Percutaneous edge-to-edge repair in patients with heart failure and secondary mitral regurgitation

21 May 2019

Paris, France, 21 May 2019. Heart failure is a common cardiovascular disorder with ominous prognosis despite significant therapeutic advances. Mitral regurgitation (MR, leaking of the mitral valve within the heart) affects at least 50% of patients with heart failure and is independently associated with worse prognosis....

A PCR statement on behalf of PCR and the European Association of Percutaneous Cardiovascular Intervention (EAPCI)

PCR STATEMENT on the clinical use of intracoronary imaging: an EAPCI expert consensus

21 May 2019

Paris, France, 21 May 2019. Intra-coronary (IC) imaging has been available for over two decades. Technological advances, with the development of new modalities and improvements in the software to facilitate “real-time” analysis and decision making, have seen an increased use for both diagnostic assessment and the...

PCR STATEMENT on the clinical use of intracoronary imaging: an EAPCI expert consensus

Tricuspid Regurgitation (TR) management with the Cardioband Tricuspid System

Georg Nickenig and Axel Linke from Germany describe how the Cardioband can be used to treat tricuspid regurgitation by addressing annular dilation. Watch this video to find out more about how the device is used to reduce the size of the annulus, the most suitable patients...

Tricuspid Regurgitation (TR) with the Cardioband tricuspid system

Coronary intravascular lithotripsy using Shockwave technology

In the last year the use of Shockwave technology has rapidly expanded, with more than 3,000 cases of coronary intravascular lithotripsy performed in Europe. Join Jonathan Hill (UK), Benjamin Honton (France) and Nikos Werner (Germany) as they look at the real-world applications of this technology. Find...

Coronary intravascular lithotripsy

Ultrasound renal denervation: RADIANCE-HTN SOLO results

What is the latest evidence on the efficacy and safety of ultrasound renal denervation in treating hypertension? Reintroducing antihypertensive medication to patients previously treated with renal denervation is under discussion as Felix Mahfoud, Michel Azizi and Ajay Kirtane consider the 6-month results from the RADIANCE-HTN SOLO...

Ultrasound renal denervation: RADIANCE-HTN SOLO results

Developing a successful CTO Programme (NAP)

Spyros Linardos (Greece) and Ricardo Esteves (Portugal) discuss the importance of training in developing a safe and effective CTO programme. This can only be possible with the support of the hospital directors and the help of role models. In this very long intervention, every member of...

Developing a successful CTO Programme (NAP)

Do we need new options in coronary physiology?

Which physiological index do you use? Watch Morton Kern of UC Irvine, Javier Escaned of Clinico Hospital San Carlos, and Jonathan Hill of King’s College discuss the need for new options in coronary physiology and why pressure guidewire performance matters.

This interview supported by Boston Scientific was...

New options in coronary physiology

Sirolimus-eluting DCB: update from the Eastbourne study

In this short video, Bernado Cortese (Italy) describes the interim analysis of the Eastbourne study, which is evaluating the performance of a sirolimus-eluting DCB for the treatment of any type of coronary lesion, including native vessel disease and in-stent restenosis. The Eastbourne registry is enrolling patients...

Which interventional strategy is best for diabetic patients?

Which is the best revascularisation procedure to use in diabetic patients? Join Marco Valgimigli, Rafael Romaguera and Rosli Mohd Ali as they discuss the challenges of performing percutaneous coronary intervention (PCI) in everyday clinical practice in these patients. The integration of functional assessment of intermediate lesions, intravascular...

Which interventional strategy is best for diabetic patients?
Didn’t find what you were looking for?